Garmin launches vívofit jr. 2 kid’s fitness tracker with Spider-Man themed bands and mobile app

Related video Garmin International, Inc., a unit of Garmin Ltd., today announced the vívofit jr. 2 kid’s fitness tracker with Marvel’s Spider-Man themed bands and mobile app. So much more than a fitness device, the vívofit jr. 2 provides kids with an interactive experience where activity unlocks adventure, shaping habits for lifelong health and fitness. […]

Pfizer’s 20vPnC vaccine receives Breakthrough Therapy designation from FDA

Related video Pfizer Inc. announced today that its 20-Valent Pneumococcal Conjugate Vaccine (20vPnC) candidate, PF-06482077, received Breakthrough Therapy designation from the US Food and Drug Administration (FDA) for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes in the vaccine in adults aged 18 years and older. Pfizer expects to start Phase […]

Genetic polymorphisms linked with muscle injury and stiffness

Related video To test whether sex-related genetic polymorphisms are associated with muscle injury and stiffness, Noriyuki Fuku from Juntendo University and colleagues report in the journal Medicine & Science in Sports & Exercise that ESR1 rs2234693 polymorphism is associated with both muscle injury and muscle stiffness. These findings suggest a role of estrogen in lowering […]

DePuy Synthes introduces CONCORDE LIFT Expandable Interbody Device at EUROSPINE 2018

Related video DePuy Synthes, part of the Johnson & Johnson Medical Devices Companies today unveiled the CONCORDE LIFT Expandable Interbody Device to European Surgeons at the EUROSPINE 2018 Meeting, taking place in Barcelona, Spain. The CONCORDE LIFT Implant is designed to treat patients suffering from degenerative disc disease by restoring disc height between vertebrae and […]

Survey: 91% of people around the world believe medical research will result in dementia cure

Related video A new survey from Novartis, Amgen and Banner Alzheimer’s Institute, along with Alzheimer’s Disease International, shows that 91% of people from around the world believe medical research will result in a treatment for dementia. The study also showed that 60% of those adults believe a cure will be developed in their lifetime. Alzheimer’s […]

LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines

Related video Applied DNA Sciences Inc. (“Applied DNA” or the “Company”) announced today that LineaRx, Inc. (“LineaRx”), its wholly-owned subsidiary focused on next-generation biotherapeutics, has signed a Joint Development Agreement (the “Agreement”) with Takis S.R.L. and Evvivax S.R.L. (“Takis/Evvivax”), biotechnology companies focused on the discovery and development of DNA based anti-cancer vaccines for the human […]